Abstract
Are physicians neglecting the risk of heart failure in diabetic patients who are receiving sulfonylureas? Lessons from the TOSCA.IT trial.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have